Journal of Medicinal Chemistry p. 3678 - 3700 (2020)
Update date:2022-08-15
Topics:
Pan, Zhaoping
Li, Xiang
Wang, Yujia
Jiang, Qinglin
Jiang, Li
Zhang, Min
Zhang, Nan
Wu, Fengbo
Liu, Bo
He, Gu
Bromodomain-containing protein 4 (BRD4) and histone deacetylases (HDAC) are both attractive epigenetic targets in cancer and other chronic diseases. Based on the integrated fragment-based drug design, synthesis, and in vitro and in vivo evaluations, a series of novel thieno[2,3-d]pyrimidine-based hydroxamic acid derivatives are discovered as selective BRD4-HDAC dual inhibitors. Compound 17c is the most potent inhibitor for BRD4 and HDAC with IC50 values at nanomolar levels, as well as the expression level of c-Myc, and increases the acetylation of histone H3. Moreover, 17c presents inhibitory effects on the proliferation of colorectal carcinoma (CRC) cells via inducing autophagic cell death. It also has a good pharmacokinetic profile in rats and oral bioavailability of 40.5%. In the HCT-116 xenograft in vivo models, 17c displays potent inhibitory efficiency on tumor growth by inducing autophagic cell death and suppressing IL6-JAK-STAT signaling pathways. Our results suggest that the BRD4-HDAC dual inhibition might be an attractive therapeutic strategy for CRC.
View MoreJewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Shanghai Yuantai Chemical Products Co., Ltd
Contact:021--66129803
Address:Chengyin Road,Shanghai,China
Hebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Contact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Shanghai Mokai Pharmaceutical Co.,Ltd
Contact:021-60257269
Address:Rm506,No.915,Zhenbei Road,Shanghai,200333,China
Doi:10.1021/ja0258172
(2002)Doi:10.1016/S0277-5387(97)00176-9
(1997)Doi:10.1016/S0040-4020(01)92599-2
(1968)Doi:10.1248/cpb.45.1642
(1997)Doi:10.1016/s0020-1693(97)05746-0
(1997)Doi:10.1055/s-1997-991
(1997)